AtriCure (ATRC) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free ATRC Stock Alerts $20.89 -1.33 (-5.99%) (As of 05/3/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAtriCure (NASDAQ:ATRC) Price Target Cut to $34.00americanbankingnews.com - May 6 at 3:44 AMJustin J. Noznesky Sells 1,500 Shares of AtriCure, Inc. (NASDAQ:ATRC) Stockamericanbankingnews.com - May 5 at 6:36 AMAtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Targetfinance.yahoo.com - May 4 at 7:14 PMAtriCure, Inc. (NASDAQ:ATRC) Insider Sells $36,135.00 in Stockinsidertrades.com - May 4 at 8:27 AMAtriCure (NASDAQ:ATRC) Stock Price Down 5.5% After Insider Sellingamericanbankingnews.com - May 4 at 2:58 AMAtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Buy" from Brokeragesamericanbankingnews.com - May 4 at 1:56 AMAtricure’s Strong Performance and Growth Potential Affirm Buy Ratingmarkets.businessinsider.com - May 3 at 10:28 PMAtriCure, Inc. (NASDAQ:ATRC) Insider Justin J. Noznesky Sells 1,500 Sharesmarketbeat.com - May 3 at 1:06 PMAtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - May 3 at 8:07 AMThe past three years for AtriCure (NASDAQ:ATRC) investors has not been profitablefinance.yahoo.com - May 3 at 8:07 AMAtriCure (NASDAQ:ATRC) Sets New 1-Year Low on Disappointing Earningsamericanbankingnews.com - May 3 at 1:46 AMAtricure’s Growth and Resilience Reinforce Buy Ratingmarkets.businessinsider.com - May 2 at 5:04 PMAtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 2 at 5:04 PMCanaccord Genuity Group Cuts AtriCure (NASDAQ:ATRC) Price Target to $49.00marketbeat.com - May 2 at 4:28 PMAtriCure (NASDAQ:ATRC) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSmarketbeat.com - May 2 at 1:59 PMAtriCure’s Strong Growth and Market Position Justify Buy Ratingmarkets.businessinsider.com - May 2 at 12:04 PMAtriCure (NASDAQ:ATRC) Hits New 1-Year Low on Analyst Downgrademarketbeat.com - May 2 at 10:51 AMAtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...finance.yahoo.com - May 2 at 7:03 AMATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024investorplace.com - May 1 at 10:06 PMAtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidancemarketbeat.com - May 1 at 9:50 PMAtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Lossesfinance.yahoo.com - May 1 at 8:57 PMAtriCure Reports First Quarter 2024 Financial Resultsbusinesswire.com - May 1 at 4:01 PMAtriCure is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - April 30 at 5:31 PMAtriCure to Participate in the 2024 Bank of America Securities Healthcare Conferencebusinesswire.com - April 30 at 8:00 AMAtriCure upgraded at Oppenheimer on valuationmsn.com - April 23 at 9:32 PMAtriCure (NASDAQ:ATRC) Upgraded at Oppenheimermarketbeat.com - April 23 at 7:15 AMAtriCure, Inc. (ATRC) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com - April 22 at 10:41 PMAtriCure (NASDAQ:ATRC) Reaches New 1-Year Low at $22.36marketbeat.com - April 22 at 2:53 PMFirst Week of June 21st Options Trading For AtriCure (ATRC)nasdaq.com - April 20 at 6:17 PMAtriCure launches advanced cryoablation probe to expedite surgeriesinvesting.com - April 20 at 1:16 PMAtriCure, Inc. (NASDAQ:ATRC) Shares Acquired by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 20 at 8:53 AMAtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Managementbusinesswire.com - April 18 at 8:00 AMAtriCure (NASDAQ:ATRC) Trading 3.2% Higher marketbeat.com - April 17 at 1:52 PMAtriCure (NASDAQ:ATRC) Reaches New 52-Week Low at $22.42marketbeat.com - April 16 at 11:02 AMShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Expands By 9.4%marketbeat.com - April 15 at 2:25 PMAtriCure (NASDAQ:ATRC) Reaches New 12-Month Low at $25.76marketbeat.com - April 10 at 4:23 PMAtriCure (NASDAQ:ATRC) Earns Buy Rating from Needham & Company LLCmarketbeat.com - April 10 at 8:17 AMAtriCure to Announce First Quarter 2024 Financial Resultsbusinesswire.com - April 10 at 8:00 AMAtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokeragesmarketbeat.com - April 9 at 2:15 AMInsider Selling: AtriCure, Inc. (NASDAQ:ATRC) Insider Sells 1,500 Shares of Stockmarketbeat.com - April 3 at 9:14 AMAtriCure (NASDAQ:ATRC) Hits New 12-Month Low at $27.86marketbeat.com - April 2 at 12:50 PMVanguard Group Inc. Boosts Position in AtriCure, Inc. (NASDAQ:ATRC)marketbeat.com - March 31 at 4:07 AMAtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 25.3% in Marchmarketbeat.com - March 30 at 6:35 AMAtriCure, Inc. (NASDAQ:ATRC) Shares Bought by Assenagon Asset Management S.A.marketbeat.com - March 30 at 4:51 AMATRC May 2024 30.000 callca.finance.yahoo.com - March 28 at 9:46 AMAtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - March 26 at 8:28 AMAtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drugfinance.yahoo.com - March 22 at 8:54 AMAtriCure, Inc. (NASDAQ:ATRC) Insider Sells $60,621.60 in Stockinsidertrades.com - March 21 at 10:32 AMAtriCure (NASDAQ:ATRC) Stock Price Down 3.8% on Insider Sellingmarketbeat.com - March 20 at 11:34 AMInsider Selling: AtriCure, Inc. (NASDAQ:ATRC) Insider Sells 1,885 Shares of Stockmarketbeat.com - March 20 at 10:38 AM Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. ATRC Media Mentions By Week ATRC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.000.41▲Average Medical News Sentiment ATRC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼303▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OFIX News Today ATEC News Today SRDX News Today INO News Today IART News Today MDXG News Today NVCR News Today AORT News Today FNA News Today LMAT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance Gold41 banks launch ‘crypto dollar’Stansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
